Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rowe

Showing results (471-480 of 1,408) with videos related to

Pageof 141
Sort By:
Pharmaceutical Research|February 1, 1989
The use of alpha-aminoboronic acid derivatives to stabilize peptide drugs during their intranasal absorptionM A Hussain, A B Shenvi, S M Rowe, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Successful use of recombinant activated factor VII in controlling upper gastrointestinal bleeding in a patient with relapsed acute myeloid leukemiaR Hoffman, R Eliakim, T Zuckerman, et al.
Oncogene|February 2, 1995
The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domainD S Huen, S A Henderson, D Croom-Carter, et al.
Current Drug Safety|August 12, 2008
Busulfan use in hematopoietic stem cell transplantation: pharmacology, dose adjustment, safety and efficacy in adults and childrenNorberto Krivoy, Erica Hoffer, Yael Lurie, et al.
Annals of Plastic Surgery|June 27, 2008
Acquired immune deficiency syndrome and systemic lupus erythematosis: potential causes of surgical emergencies of the handJohnny J Wirth, Kedambady P Sheka, Anup Gheewala, et al.
Pharmaceutical Research|May 30, 2002
Kinetics and mechanism of hydrolysis of efavirenzMichael B Maurin, Susan M Rowe, Karl Blom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2002
Fertility after treatment for Hodgkin's diseaseZ Blumenfeld, E Dann, I Avivi, et al.
Seminars in Hematology|September 6, 2002
Future clinical implications for farnesyltransferase inhibitors in hematologic malignanciesHagop M Kantarjian, Jorge E Cortes, Jacob M Rowe, et al.
European Journal of Immunology|March 1, 1990
Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cellsR J Murray, J M Brooks, A B Rickinson, et al.
Current Opinion in Pharmacology|November 14, 2017
The therapeutic potential of CFTR modulators for COPD and other airway diseasesGeorge M Solomon, Lianwu Fu, Steven M Rowe, et al.
Pageof 141

Showing results (471-480 of 1,408) with videos related to

Sort By:
Pageof 141
Pharmaceutical Research|February 1, 1989
The use of alpha-aminoboronic acid derivatives to stabilize peptide drugs during their intranasal absorptionM A Hussain, A B Shenvi, S M Rowe, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Successful use of recombinant activated factor VII in controlling upper gastrointestinal bleeding in a patient with relapsed acute myeloid leukemiaR Hoffman, R Eliakim, T Zuckerman, et al.
Oncogene|February 2, 1995
The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domainD S Huen, S A Henderson, D Croom-Carter, et al.
Current Drug Safety|August 12, 2008
Busulfan use in hematopoietic stem cell transplantation: pharmacology, dose adjustment, safety and efficacy in adults and childrenNorberto Krivoy, Erica Hoffer, Yael Lurie, et al.
Annals of Plastic Surgery|June 27, 2008
Acquired immune deficiency syndrome and systemic lupus erythematosis: potential causes of surgical emergencies of the handJohnny J Wirth, Kedambady P Sheka, Anup Gheewala, et al.
Pharmaceutical Research|May 30, 2002
Kinetics and mechanism of hydrolysis of efavirenzMichael B Maurin, Susan M Rowe, Karl Blom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2002
Fertility after treatment for Hodgkin's diseaseZ Blumenfeld, E Dann, I Avivi, et al.
Seminars in Hematology|September 6, 2002
Future clinical implications for farnesyltransferase inhibitors in hematologic malignanciesHagop M Kantarjian, Jorge E Cortes, Jacob M Rowe, et al.
European Journal of Immunology|March 1, 1990
Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cellsR J Murray, J M Brooks, A B Rickinson, et al.
Current Opinion in Pharmacology|November 14, 2017
The therapeutic potential of CFTR modulators for COPD and other airway diseasesGeorge M Solomon, Lianwu Fu, Steven M Rowe, et al.
Pageof 141